BRITISH JOURNAL OF HAEMATOLOGY

Identification of high‐risk DUSP22‐rearranged ALK‐negative anaplastic large cell lymphoma

A diagnostic solution for haemostasis laboratories for patients taking direct oral anticoagulants using DOAC‐Remove

Therapeutic gene editing in haematological disorders with CRISPR/Cas9

SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation

How I manage severe von Willebrand disease

New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta‐2 microglobulin in patients with diffuse large B‐cell lymphoma treated with R‐CHOP: Spanish Lymphoma Group Experience (GELTAMO)

How we manage Bing–Neel syndrome

Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma

BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome

Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosis.

Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML‐05 study

Extended follow‐up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi‐centre phase I/II Clinical Trial)

Differential expression of long non‐coding RNAs are related to proliferation and histological diversity in follicular lymphomas

Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis

Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup

Long survival in patients with Waldenström macroglobulinaemia diagnosed at a young age

Fibrin‐associated diffuse large B‐cell lymphoma

Bleeding and bruising in Osteogenesis Imperfecta: International Society on Thrombosis and Haemostasis bleeding assessment tool and haemostasis laboratory assessment in 22 individuals

CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation

Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD‐driven salvage approach

Chronic lymphocytic leukaemia: the role of T cells in a B cell disease

Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non‐hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab

A new case of heterozygous variant of the GP1BB gene responsible for macrothrombocytopenia

The evolving role of next generation sequencing in myelodysplastic syndromes

Validation of a simplified international prognostic score (IPS‐3) in patients with advanced‐stage classic Hodgkin lymphoma

Prognostic impact of interim positron emission tomography in mantle cell lymphoma patients treated with frontline R‐CHOP

Mortality‐associated immunological abnormalities in trichothiodystrophy: correlation of reduced levels of immunoglobulin and neutrophils with poor patient survival

Gabapentin alleviates chronic spontaneous pain and acute hypoxia‐related pain in a mouse model of sickle cell disease

Real world experience at a single centre using low dose direct oral anticoagulants after unprovoked venous thromboembolism

Systemic EBV‐positive T‐cell lymphoma of childhood mimicking anaplastic large cell lymphoma

Stigmata of amyloidosis; external manifestations of internal disease

Anthropometric factors and risk of myeloid leukaemias and myelodysplastic syndromes: a prospective study and meta‐analysis

Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations

Impaired immune responses to herpesviruses and microbial ligands in patients with MonoMAC

A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy

Waldenström macroglobulinaemia terminating in acute lymphoblastic leukaemia after treatment with fludarabine

Bone marrow metastases mimicking acute leukaemia

Mucormycosis in children with haematological malignancies is a salvageable disease: a report from the Israeli Study Group of Childhood Leukemia

Issue Information

Analysis of human papillomavirus infection and leukaemic infiltrate in cutaneous squamous cell carcinoma from patients with chronic lymphocytic leukaemia

“Fine‐tuning cytoreduction in resistant multiple myeloma ‐ progress here, too”?

Complication rates of central venous access devices in patients with inherited bleeding disorders in Australia

Sickle related events following cardiac catheterisation: risk implication for other invasive procedures

Primary cutaneous acral CD8+ T‐cell lymphomas relapse more frequently in younger patients

Efficacy of lenalidomide in high‐risk diffuse large B‐cell lymphoma

Refining statistics clarifies leukaemic stem cell genomics

Assessing complete remission status in incurable follicular lymphomas, to what purpose?